Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	GTPase activator activity	TBC1D3E ARHGAP32 TBC1D3 TBC1D3H TBC1D3L TBC1D3D MYO9B CHN2 TBC1D3C TBC1D3B TBC1D3I ARHGAP20 TBC1D3G IQGAP3 ARAP1 TBC1D3K TBC1D3F	2.26e-10	279	168	17	GO:0005096
GeneOntologyMolecularFunction	nucleoside-triphosphatase regulator activity	TBC1D3E ARHGAP32 TBC1D3 TBC1D3H TBC1D3L TBC1D3D MYCBP2 MYO9B IQSEC2 CHN2 TBC1D3C TBC1D3B TBC1D3I ARHGAP20 TBC1D3G IQGAP3 ARAP1 TBC1D3K TBC1D3F	5.77e-08	507	168	19	GO:0060589
GeneOntologyMolecularFunction	GTPase regulator activity	TBC1D3E ARHGAP32 TBC1D3 TBC1D3H TBC1D3L TBC1D3D MYCBP2 MYO9B IQSEC2 CHN2 TBC1D3C TBC1D3B TBC1D3I ARHGAP20 TBC1D3G IQGAP3 ARAP1 TBC1D3K TBC1D3F	5.77e-08	507	168	19	GO:0030695
GeneOntologyMolecularFunction	enzyme activator activity	TBC1D3E ARHGAP32 ERCC5 TBC1D3 TBC1D3H TBC1D3L TBC1D3D MYO9B CHN2 TBC1D3C TBC1D3B RAD50 BMP2 TBC1D3I ARHGAP20 TBC1D3G IQGAP3 ARAP1 TBC1D3K TBC1D3F	6.92e-07	656	168	20	GO:0008047
GeneOntologyMolecularFunction	glucan 1,4-alpha-glucosidase activity	MGAM MGAM2	7.04e-05	2	168	2	GO:0004339
GeneOntologyMolecularFunction	molecular function activator activity	TBC1D3E ARHGAP32 ERCC5 TBC1D3 TBC1D3H TBC1D3L TBC1D3D MYO9B CHN2 TBC1D3C TBC1D3B LGALS3 RAD50 BMP2 BMP6 DNAJC10 ENDOU TBC1D3I ARHGAP20 TBC1D3G IQGAP3 ARAP1 TBC1D3K TBC1D3F	1.05e-04	1233	168	24	GO:0140677
GeneOntologyMolecularFunction	RNA polymerase II transcription regulatory region sequence-specific DNA binding	ZNF211 KCNH8 TRPS1 ZNF571 ZNF397 ZBTB26 ZNF619 ZNF785 ZNF354C ZNF461 ZNF71 ZNF526 USF3 VENTX ZNF530 NFATC1 UBP1 ZNF197 ZNF283 ZBTB5 NR5A1 ZNF841 ZNF606 UTY ZNF583 ZNF287	2.18e-04	1459	168	26	GO:0000977
GeneOntologyMolecularFunction	transition metal ion binding	SEMG1 SEMG2 DOHH NUDT7 B4GALT7 MYCBP2 MYO9B TRPS1 TAB2 CPD SAMHD1 CA10 ADCY2 S100A12 CRYZ USP51 ENDOU NR5A1 DMD ZMAT1 ALOX12 PRM2	4.20e-04	1189	168	22	GO:0046914
GeneOntologyMolecularFunction	cis-regulatory region sequence-specific DNA binding	ZNF211 KCNH8 ZNF571 ZNF397 ZBTB26 ZNF354C TIPARP ZNF461 ZNF71 ZNF526 VENTX ZNF530 NFATC1 MTOR UBP1 ZNF197 ZNF283 NR5A1 ZNF841 ZNF606 UTY ZNF583 ZNF287	4.21e-04	1271	168	23	GO:0000987
GeneOntologyMolecularFunction	alpha-1,4-glucosidase activity	MGAM MGAM2	6.92e-04	5	168	2	GO:0004558
GeneOntologyMolecularFunction	DNA-binding transcription factor activity, RNA polymerase II-specific	ZNF211 TRPS1 ZNF571 ZNF397 ZBTB26 ZNF619 ZNF785 ZNF354C ZNF461 ZNF71 ZNF526 USF3 VENTX ZNF530 NFATC1 UBP1 ZNF197 ZNF283 ZBTB5 NR5A1 ZNF841 ZNF606 ZNF583 ZNF287	7.64e-04	1412	168	24	GO:0000981
GeneOntologyMolecularFunction	enzyme regulator activity	TBC1D3E ARHGAP32 ERCC5 TBC1D3 TBC1D3H TBC1D3L TBC1D3D MYCBP2 MYO9B IQSEC2 CHN2 TBC1D3C TBC1D3B LGALS3 RAD50 BMP2 IGBP1 TBC1D3I ARHGAP20 TBC1D3G IQGAP3 ARAP1 TBC1D3K TBC1D3F	8.11e-04	1418	168	24	GO:0030234
GeneOntologyBiologicalProcess	activation of GTPase activity	TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F	1.28e-09	109	166	11	GO:0090630
GeneOntologyBiologicalProcess	positive regulation of GTPase activity	TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D MYO9B CHN2 TBC1D3C TBC1D3B TBC1D3I TBC1D3G ARAP1 TBC1D3K TBC1D3F	1.16e-08	244	166	14	GO:0043547
GeneOntologyBiologicalProcess	regulation of GTPase activity	TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D MYO9B CHN2 TBC1D3C TBC1D3B MTOR TBC1D3I TBC1D3G ARAP1 TBC1D3K TBC1D3F	9.23e-08	335	166	15	GO:0043087
GeneOntologyBiologicalProcess	positive regulation of hydrolase activity	SEMG1 SEMG2 TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D MYO9B CHN2 TBC1D3C TBC1D3B BMP2 MTOR TBC1D3I TBC1D3G ARAP1 TBC1D3K TBC1D3F	1.20e-07	499	166	18	GO:0051345
GeneOntologyBiologicalProcess	positive regulation of catalytic activity	SEMG1 SEMG2 TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D MYO9B TAB2 CHN2 TBC1D3C ADCY2 TBC1D3B RAD50 BMP2 S100A12 MTOR TENM1 PDE5A TBC1D3I TBC1D3G ARAP1 TBC1D3K TBC1D3F	2.61e-06	1028	166	24	GO:0043085
GeneOntologyBiologicalProcess	positive regulation of molecular function	SEMG1 SEMG2 TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D MYO9B USP9X TAB2 CHN2 TBC1D3C ADCY2 TBC1D3B RYR2 RAD50 BMP2 S100A12 DNAJC10 MTOR TENM1 PDE5A PLCG2 DMD TBC1D3I TBC1D3G ARAP1 TBC1D3K TBC1D3F	3.52e-06	1430	166	29	GO:0044093
GeneOntologyBiologicalProcess	regulation of hydrolase activity	SEMG1 SEMG2 TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D MYO9B CHN2 TBC1D3C TBC1D3B LGALS3 BMP2 IGBP1 MTOR TBC1D3I TBC1D3G ARAP1 TBC1D3K TBC1D3F	2.73e-05	878	166	20	GO:0051336
GeneOntologyBiologicalProcess	replication fork processing	ATR ATRX SAMHD1 RAD50 POLQ	6.09e-05	52	166	5	GO:0031297
GeneOntologyBiologicalProcess	negative regulation of reproductive process	SEMG1 SEMG2 RPS6KA2 DDB1 MAEL NR5A1	8.31e-05	89	166	6	GO:2000242
GeneOntologyBiologicalProcess	DNA-templated DNA replication maintenance of fidelity	ATR ATRX SAMHD1 RAD50 POLQ	1.21e-04	60	166	5	GO:0045005
MousePheno	abnormal Muller cell morphology	LAMA1 SYNE2 EML1 DMD	1.84e-05	20	114	4	MP:0005547
Domain	RabGAP-TBC	TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D31 TBC1D3I TBC1D3G TBC1D3K TBC1D3F	1.15e-12	53	167	11	PF00566
Domain	Rab-GTPase-TBC_dom	TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D31 TBC1D3I TBC1D3G TBC1D3K TBC1D3F	1.79e-12	55	167	11	IPR000195
Domain	TBC_RABGAP	TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D31 TBC1D3I TBC1D3G TBC1D3K TBC1D3F	1.79e-12	55	167	11	PS50086
Domain	TBC	TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F	1.52e-11	49	167	10	SM00164
Domain	HELP	EML4 EML6 EML2 EML1	9.12e-08	6	167	4	PF03451
Domain	HELP	EML4 EML6 EML2 EML1	9.12e-08	6	167	4	IPR005108
Domain	Znf_C2H2-like	ZNF211 TRPS1 ZNF576 ZNF571 ZNF397 ZBTB26 ZNF619 ZNF785 ZNF354C ZNF461 ZNF71 ZNF526 ZNF530 ZNF197 ZNF804B ZNF283 ZBTB5 ZNF841 ZNF606 ZMAT1 ZNF583 RNF138 ZNF287	6.92e-07	796	167	23	IPR015880
Domain	Znf_C2H2	ZNF211 TRPS1 ZNF576 ZNF571 ZNF397 ZBTB26 ZNF619 ZNF785 ZNF354C ZNF461 ZNF71 ZNF526 ZNF530 ZNF197 ZNF804B ZNF283 ZBTB5 ZNF841 ZNF606 ZMAT1 ZNF583 RNF138 ZNF287	8.39e-07	805	167	23	IPR007087
Domain	ZnF_C2H2	ZNF211 TRPS1 ZNF576 ZNF571 ZNF397 ZBTB26 ZNF619 ZNF785 ZNF354C ZNF461 ZNF71 ZNF526 ZNF530 ZNF197 ZNF804B ZNF283 ZBTB5 ZNF841 ZNF606 ZMAT1 ZNF583 RNF138 ZNF287	8.95e-07	808	167	23	SM00355
Domain	zf-C2H2	ZNF211 TRPS1 ZNF576 ZNF571 ZNF397 ZBTB26 ZNF619 ZNF785 ZNF354C ZNF461 ZNF71 ZNF526 ZNF530 ZNF197 ZNF283 ZBTB5 ZNF841 ZNF606 ZNF583 ZNF287	4.00e-06	693	167	20	PF00096
Domain	zf-C2H2_6	ZNF211 ZNF576 ZNF571 ZNF619 ZNF354C ZNF461 ZNF71 ZNF526 ZNF530 ZNF197 ZNF283 ZNF841 ZNF606	5.15e-06	314	167	13	PF13912
Domain	ZINC_FINGER_C2H2_2	ZNF211 TRPS1 ZNF576 ZNF571 ZNF397 ZBTB26 ZNF619 ZNF785 ZNF354C ZNF461 ZNF71 ZNF526 ZNF530 ZNF197 ZNF804B ZNF283 ZBTB5 ZNF841 ZNF606 ZNF583 ZNF287	5.99e-06	775	167	21	PS50157
Domain	ZINC_FINGER_C2H2_1	ZNF211 TRPS1 ZNF576 ZNF571 ZNF397 ZBTB26 ZNF619 ZNF785 ZNF354C ZNF461 ZNF71 ZNF526 ZNF530 ZNF197 ZNF804B ZNF283 ZBTB5 ZNF841 ZNF606 ZNF583 ZNF287	6.23e-06	777	167	21	PS00028
Domain	Znf_C2H2/integrase_DNA-bd	ZNF211 ZNF576 ZNF571 ZNF397 ZBTB26 ZNF619 ZNF785 ZNF354C ZNF461 ZNF71 ZNF526 ZNF530 ZNF197 ZNF283 ZBTB5 ZNF841 ZNF606 ZNF583 ZNF287	1.49e-05	694	167	19	IPR013087
Domain	-	ZNF211 ZNF576 ZNF571 ZNF397 ZBTB26 ZNF619 ZNF785 ZNF354C ZNF461 ZNF71 ZNF526 ZNF530 ZNF197 ZNF283 ZBTB5 ZNF841 ZNF606 ZNF583	3.86e-05	679	167	18	3.30.160.60
Domain	Spectrin	ACTN1 SPTBN5 SYNE2 DMD	4.78e-05	23	167	4	PF00435
Domain	ACTININ_2	ACTN1 SPTBN5 SYNE2 DMD	4.78e-05	23	167	4	PS00020
Domain	ACTININ_1	ACTN1 SPTBN5 SYNE2 DMD	4.78e-05	23	167	4	PS00019
Domain	Actinin_actin-bd_CS	ACTN1 SPTBN5 SYNE2 DMD	4.78e-05	23	167	4	IPR001589
Domain	WW	MAGI1 WWOX NEDD4 HECW2 DMD	6.09e-05	47	167	5	PF00397
Domain	WW	MAGI1 WWOX NEDD4 HECW2 DMD	6.75e-05	48	167	5	SM00456
Domain	Semenogelin	SEMG1 SEMG2	7.95e-05	2	167	2	PF05474
Domain	Semenogelin	SEMG1 SEMG2	7.95e-05	2	167	2	IPR008836
Domain	WW_DOMAIN_1	MAGI1 WWOX NEDD4 HECW2 DMD	9.07e-05	51	167	5	PS01159
Domain	WW_DOMAIN_2	MAGI1 WWOX NEDD4 HECW2 DMD	9.07e-05	51	167	5	PS50020
Domain	WW_dom	MAGI1 WWOX NEDD4 HECW2 DMD	9.96e-05	52	167	5	IPR001202
Domain	Quinoprotein_ADH-like_supfam	EML4 EML6 EML2 OLFM1 EML1	1.09e-04	53	167	5	IPR011047
Domain	Spectrin_repeat	ACTN1 SPTBN5 SYNE2 DMD	1.23e-04	29	167	4	IPR002017
Domain	Rho_GTPase_activation_prot	ARHGAP32 MYO9B CHN2 ARHGAP20 IQGAP3 ARAP1	1.38e-04	88	167	6	IPR008936
Domain	SPEC	ACTN1 SPTBN5 SYNE2 DMD	1.82e-04	32	167	4	SM00150
Domain	Spectrin/alpha-actinin	ACTN1 SPTBN5 SYNE2 DMD	1.82e-04	32	167	4	IPR018159
Domain	RhoGAP	ARHGAP32 MYO9B CHN2 ARHGAP20 ARAP1	2.31e-04	62	167	5	SM00324
Domain	RhoGAP	ARHGAP32 MYO9B CHN2 ARHGAP20 ARAP1	2.49e-04	63	167	5	PF00620
Domain	RhoGAP_dom	ARHGAP32 MYO9B CHN2 ARHGAP20 ARAP1	2.68e-04	64	167	5	IPR000198
Domain	RHOGAP	ARHGAP32 MYO9B CHN2 ARHGAP20 ARAP1	2.68e-04	64	167	5	PS50238
Domain	-	ARHGAP32 MYO9B CHN2 ARHGAP20 ARAP1	2.68e-04	64	167	5	1.10.555.10
Domain	CH	ACTN1 SPTBN5 SYNE2 DMD IQGAP3	2.88e-04	65	167	5	SM00033
Domain	GATA_ZN_FINGER_1	ATRX TRPS1 RERE	3.61e-04	16	167	3	PS00344
Domain	GATA_ZN_FINGER_2	ATRX TRPS1 RERE	3.61e-04	16	167	3	PS50114
Domain	KRAB	ZNF211 ZNF571 ZNF785 ZNF354C ZNF461 ZNF530 ZNF197 ZNF283 ZNF606 ZNF583 ZNF287	3.88e-04	358	167	11	PS50805
Domain	KRAB	ZNF211 ZNF571 ZNF785 ZNF354C ZNF461 ZNF530 ZNF197 ZNF283 ZNF606 ZNF583 ZNF287	3.88e-04	358	167	11	PF01352
Domain	CH	ACTN1 SPTBN5 SYNE2 DMD IQGAP3	4.08e-04	70	167	5	PF00307
Domain	-	ACTN1 SPTBN5 SYNE2 DMD IQGAP3	4.35e-04	71	167	5	1.10.418.10
Domain	Gal_mutarotase_N	MGAM MGAM2	4.71e-04	4	167	2	IPR031727
Domain	NtCtMGAM_N	MGAM MGAM2	4.71e-04	4	167	2	PF16863
Domain	CH	ACTN1 SPTBN5 SYNE2 DMD IQGAP3	4.95e-04	73	167	5	PS50021
Domain	KRAB	ZNF211 ZNF571 ZNF785 ZNF354C ZNF461 ZNF530 ZNF197 ZNF283 ZNF606 ZNF583 ZNF287	5.00e-04	369	167	11	SM00349
Domain	KRAB	ZNF211 ZNF571 ZNF785 ZNF354C ZNF461 ZNF530 ZNF197 ZNF283 ZNF606 ZNF583 ZNF287	5.11e-04	370	167	11	IPR001909
Domain	CH-domain	ACTN1 SPTBN5 SYNE2 DMD IQGAP3	5.61e-04	75	167	5	IPR001715
Domain	FATC	ATR MTOR	7.81e-04	5	167	2	PF02260
Domain	Quino_amine_DH_bsu	NBAS OLFM1 EML1	9.54e-04	22	167	3	IPR011044
Domain	Glyco_hydro_31_AS	MGAM MGAM2	1.16e-03	6	167	2	IPR030458
Domain	FAT	ATR MTOR	1.16e-03	6	167	2	PS51189
Domain	FATC	ATR MTOR	1.16e-03	6	167	2	PS51190
Domain	FAT	ATR MTOR	1.16e-03	6	167	2	PF02259
Domain	PIK-rel_kinase_FAT	ATR MTOR	1.16e-03	6	167	2	IPR003151
Domain	FATC_dom	ATR MTOR	1.16e-03	6	167	2	IPR003152
Domain	PIK_FAT	ATR MTOR	1.16e-03	6	167	2	IPR014009
Domain	FATC	ATR MTOR	1.16e-03	6	167	2	SM01343
Domain	Glyco_hydro_31	MGAM MGAM2	1.62e-03	7	167	2	IPR000322
Domain	Glyco_hydro_31	MGAM MGAM2	1.62e-03	7	167	2	PF01055
Domain	Myosin_TH1	MYO1G MYO1C	1.62e-03	7	167	2	PF06017
Domain	Myosin_TH1	MYO1G MYO1C	1.62e-03	7	167	2	IPR010926
Domain	TH1	MYO1G MYO1C	1.62e-03	7	167	2	PS51757
Domain	GLYCOSYL_HYDROL_F31_1	MGAM MGAM2	1.62e-03	7	167	2	PS00129
Domain	Trefoil	MGAM MGAM2	2.15e-03	8	167	2	PF00088
Domain	-	OGT ATR ST7 MAU2 MTOR TTC29 UTY	2.64e-03	207	167	7	1.25.40.10
Domain	P_TREFOIL_2	MGAM MGAM2	2.75e-03	9	167	2	PS51448
Domain	PD	MGAM MGAM2	2.75e-03	9	167	2	SM00018
Domain	USP_CS	USP9X USP9Y USP51 USP27X	2.89e-03	66	167	4	IPR018200
Pathway	WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME	TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K	1.58e-07	99	120	9	M46448
Pubmed	TBC1D3, a hominoid oncoprotein, is encoded by a cluster of paralogues located on chromosome 17q12.	TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F	2.56e-26	11	169	11	16863688
Pubmed	DNA sequence of human chromosome 17 and analysis of rearrangement in the human lineage.	TBC1D3E TBC1D3 TBC1D3H TBC1D3D CEP295NL TBC1D3B TBC1D3G TBC1D3F	3.02e-09	74	169	8	16625196
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	AMD1 MAGI1 OGT KCNH8 WWOX ATRX MYCBP2 PTBP2 ST7 RPS6KA2 TRPS1 CPD ATP8B1 STK32C SELENON SESN1 ZNF461 USF3 NFATC1 RERE CSMD1 CNOT1 ZMAT1 ARAP1	2.64e-07	1489	169	24	28611215
Pubmed	PRC17, a novel oncogene encoding a Rab GTPase-activating protein, is amplified in prostate cancer.	TBC1D3 TBC1D3D TBC1D3F	4.49e-07	4	169	3	12359748
Pubmed	Identification of novel sequences in the repertoire of hypervariable TRE17 genes from immortalized nonmalignant and malignant human keratinocytes.	TBC1D3 TBC1D3D TBC1D3F	4.49e-07	4	169	3	8406013
Pubmed	Charting the molecular network of the drug target Bcr-Abl.	SEMG1 SEMG2 MYO1C USP9X ACTN1 USP9Y DDB1 CNOT1 VARS1 ARAP1	7.95e-07	266	169	10	19380743
Pubmed	The Tre2 (USP6) oncogene is a hominoid-specific gene.	TBC1D3 TBC1D3D TBC1D3C	1.12e-06	5	169	3	12604796
Pubmed	Human TRE17 oncogene is generated from a family of homologous polymorphic sequences by single-base changes.	TBC1D3 TBC1D3D TBC1D3F	1.12e-06	5	169	3	8471161
Pubmed	Crystal structure of EML1 reveals the basis for Hsp90 dependence of oncogenic EML4-ALK by disruption of an atypical β-propeller domain.	EML4 EML2 EML1	2.23e-06	6	169	3	24706829
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	SEMG1 OGT DCDC1 MYO1C TRPS1 SCEL DDB1 ENKD1 ZNF461 RAD50 ZNF526 PELO DNAJC10 CHD5 LRP2 SIGLEC1 RERE CSMD1 ANKS3	2.35e-06	1116	169	19	31753913
Pubmed	Microtubule association of EML proteins and the EML4-ALK variant 3 oncoprotein require an N-terminal trimerization domain.	EML4 EML2 EML1	3.89e-06	7	169	3	25740311
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	OGT ATRX MYCBP2 VPS39 USP9X IQSEC2 TRPS1 ZNF619 ACTN1 USP9Y ZNF785 RSPH1 ZNF197 LRP2 ZBTB5 OLFM1 ZNF841 ZNF606 ZNF583 VARS1	4.81e-06	1285	169	20	35914814
Pubmed	The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1.	USP9X ACTN1 DDB1 RYR2 RAD50 SYNE2 DMD ARHGAP20	5.89e-06	197	169	8	20811636
Pubmed	The protein kinase complement of the human genome.	STK32B STYK1 STK32C STK32A	1.01e-05	28	169	4	12471243
Pubmed	CRL4AMBRA1 targets Elongin C for ubiquitination and degradation to modulate CRL5 signaling.	OGT USP9X SAMHD1 DDB1 IGBP1 PELO	1.53e-05	108	169	6	30166453
Pubmed	The functional landscape of Hsp27 reveals new cellular processes such as DNA repair and alternative splicing and proposes novel anticancer targets.	AMD1 ERCC5 ACTN1 TBC1D3B NBAS IGBP1 PELO ZNF197	1.55e-05	225	169	8	25277244
Pubmed	Crosstalk between RyR2 oxidation and phosphorylation contributes to cardiac dysfunction in mice with Duchenne muscular dystrophy.	RYR2 DMD	2.35e-05	2	169	2	26555638
Pubmed	Bone Morphogenetic Protein-2 (BMP-2) Activates NFATc1 Transcription Factor via an Autoregulatory Loop Involving Smad/Akt/Ca2+ Signaling.	BMP2 NFATC1	2.35e-05	2	169	2	26472929
Pubmed	Ganglioside GM1 mediates decapacitation effects of SVS2 on murine spermatozoa.	SEMG1 SEMG2	2.35e-05	2	169	2	18753612
Pubmed	Functional implications of membrane modification with semenogelins for inhibition of sperm motility in humans.	SEMG1 SEMG2	2.35e-05	2	169	2	19089943
Pubmed	Ubiquitin-specific protease activity of USP9Y, a male infertility gene on the Y chromosome.	USP9X USP9Y	2.35e-05	2	169	2	12895410
Pubmed	Gene structure of semenogelin I and II. The predominant proteins in human semen are encoded by two homologous genes on chromosome 20.	SEMG1 SEMG2	2.35e-05	2	169	2	1517240
Pubmed	Nedd4 E3 ubiquitin ligase promotes cell proliferation and autophagy.	NEDD4 MTOR	2.35e-05	2	169	2	25809873
Pubmed	Skeletal muscle-specific overexpression of IGFBP-2 promotes a slower muscle phenotype in healthy but not dystrophic mdx mice and does not affect the dystrophic pathology.	IGFBP2 DMD	2.35e-05	2	169	2	27544574
Pubmed	[Expression of recombinant human BMP6 in CHO cells by fused to the signal peptide and propeptide of another homologue protein].	BMP2 BMP6	2.35e-05	2	169	2	17577985
Pubmed	Expression of insulin-like growth factor binding protein-2 by MCF-7 breast cancer cells is regulated through the phosphatidylinositol 3-kinase/AKT/mammalian target of rapamycin pathway.	IGFBP2 MTOR	2.35e-05	2	169	2	17289850
Pubmed	The structure of the semenogelin gene locus--nucleotide sequence of the intergenic and the flanking DNA.	SEMG1 SEMG2	2.35e-05	2	169	2	8654389
Pubmed	Seminal vesicle protein SVS2 is required for sperm survival in the uterus.	SEMG1 SEMG2	2.35e-05	2	169	2	24591616
Pubmed	Human Semenogelin 1 Promotes Sperm Survival in the Mouse Female Reproductive Tract.	SEMG1 SEMG2	2.35e-05	2	169	2	32486486
Pubmed	The Drosophila developmental gene fat facets has a human homologue in Xp11.4 which escapes X-inactivation and has related sequences on Yq11.2.	USP9X USP9Y	2.35e-05	2	169	2	8922996
Pubmed	Sildenafil reduces respiratory muscle weakness and fibrosis in the mdx mouse model of Duchenne muscular dystrophy.	PDE5A DMD	2.35e-05	2	169	2	22653783
Pubmed	The decrease of expression of ryanodine receptor sub-type 2 is reversed by gentamycin sulphate in vascular myocytes from mdx mice.	RYR2 DMD	2.35e-05	2	169	2	19298530
Pubmed	The cloning of a rapidly evolving seminal-vesicle-transcribed gene encoding the major clot-forming protein of mouse semen.	SEMG1 SEMG2	2.35e-05	2	169	2	8631362
Pubmed	Sequence and expression patterns of a human EMAP-related protein-2 (HuEMAP-2).	EML2 EML1	2.35e-05	2	169	2	10521658
Pubmed	Transgenic expression of Laminin α1 chain does not prevent muscle disease in the mdx mouse model for Duchenne muscular dystrophy.	LAMA1 DMD	2.35e-05	2	169	2	21435454
Pubmed	BMP-2/6 heterodimer is more effective than BMP-2 or BMP-6 homodimers as inductor of differentiation of human embryonic stem cells.	BMP2 BMP6	2.35e-05	2	169	2	20567515
Pubmed	Deubiquitinase USP9X loss sensitizes renal cancer cells to mTOR inhibition.	USP9X MTOR	2.35e-05	2	169	2	37260183
Pubmed	[Isolation and structure determination of two peptides occurring in human seminal plasma].	SEMG1 SEMG2	2.35e-05	2	169	2	2757795
Pubmed	Isolation and characterization of the major gel proteins in human semen, semenogelin I and semenogelin II.	SEMG1 SEMG2	2.35e-05	2	169	2	8665951
Pubmed	SEMG1/2 augment energy metabolism of tumor cells.	SEMG1 SEMG2	2.35e-05	2	169	2	33311447
Pubmed	Bone morphogenetic protein-2 and -6 heterodimer illustrates the nature of ligand-receptor assembly.	BMP2 BMP6	2.35e-05	2	169	2	20484413
Pubmed	Rapamycin attenuates endothelial apoptosis induced by low shear stress via mTOR and sestrin1 related redox regulation.	SESN1 MTOR	2.35e-05	2	169	2	24587596
Pubmed	Distribution and tissue expression of semenogelin I and II in man as demonstrated by in situ hybridization and immunocytochemistry.	SEMG1 SEMG2	2.35e-05	2	169	2	8833737
Pubmed	Semen-coagulating protein, SVS2, in mouse seminal plasma controls sperm fertility.	SEMG1 SEMG2	2.35e-05	2	169	2	17123940
Pubmed	WWOX activates autophagy to alleviate lipopolysaccharide-induced acute lung injury by regulating mTOR.	WWOX MTOR	2.35e-05	2	169	2	36621327
Pubmed	Bone morphogenetic proteins 2 and 6, expressed in arthritic synovium, are regulated by proinflammatory cytokines and differentially modulate fibroblast-like synoviocyte apoptosis.	BMP2 BMP6	2.35e-05	2	169	2	14558086
Pubmed	Usp9y (ubiquitin-specific protease 9 gene on the Y) is associated with a functional promoter and encodes an intact open reading frame homologous to Usp9x that is under selective constraint.	USP9X USP9Y	2.35e-05	2	169	2	12925892
Pubmed	The membrane-associated guanylate kinase protein MAGI-1 binds megalin and is present in glomerular podocytes.	MAGI1 LRP2	2.35e-05	2	169	2	11274227
Pubmed	Evolution of the hominoid semenogelin genes, the major proteins of ejaculated semen.	SEMG1 SEMG2	2.35e-05	2	169	2	14629036
Pubmed	Semenogelin I and II, the predominant human seminal plasma proteins, are also expressed in non-genital tissues.	SEMG1 SEMG2	2.35e-05	2	169	2	12200457
Pubmed	Muscle protein synthesis, mTORC1/MAPK/Hippo signaling, and capillary density are altered by blocking of myostatin and activins.	MTOR DMD	2.35e-05	2	169	2	23115080
Pubmed	Postnatal eye size in mice is controlled by SREBP2-mediated transcriptional repression of Lrp2 and Bmp2.	BMP2 LRP2	2.35e-05	2	169	2	35833708
Pubmed	Quantification of seminal plasma motility inhibitor/semenogelin in human seminal plasma.	SEMG1 SEMG2	2.35e-05	2	169	2	14581514
Pubmed	Seminal vesicle secretion 2 acts as a protectant of sperm sterols and prevents ectopic sperm capacitation in mice.	SEMG1 SEMG2	2.35e-05	2	169	2	25395676
Pubmed	WWOX suppresses autophagy for inducing apoptosis in methotrexate-treated human squamous cell carcinoma.	WWOX MTOR	2.35e-05	2	169	2	24008736
Pubmed	Trps1 acts as a regulator of Sf-1 transcription and testosterone synthesis in mouse Leydig cells.	TRPS1 NR5A1	2.35e-05	2	169	2	37531013
Pubmed	Dystrophin is required for the normal function of the cardio-protective K(ATP) channel in cardiomyocytes.	KCNJ5 DMD	2.35e-05	2	169	2	22066028
Pubmed	Nanoscale remodeling of ryanodine receptor cluster size underlies cerebral microvascular dysfunction in Duchenne muscular dystrophy.	RYR2 DMD	2.35e-05	2	169	2	30181262
Pubmed	Peptides released by physiological cleavage of semen coagulum proteins form amyloids that enhance HIV infection.	SEMG1 SEMG2	2.35e-05	2	169	2	22177559
Pubmed	Functional preservation of duplicated pair for RSVS III gene in the REST locus of rat 3q42.	SEMG1 SEMG2	2.35e-05	2	169	2	15582586
Pubmed	Expression of semenogelins I and II and its prognostic significance in human prostate cancer.	SEMG1 SEMG2	2.35e-05	2	169	2	21557275
Pubmed	Rescuing the aberrant sex development of H3K9 demethylase Jmjd1a-deficient mice by modulating H3K9 methylation balance.	USP9Y NR5A1 UTY	2.40e-05	12	169	3	28949961
Pubmed	RERE deficiency leads to decreased expression of GATA4 and the development of ventricular septal defects.	BMP2 NFATC1 RERE	2.40e-05	12	169	3	30061196
Pubmed	Comparative interactome analysis of α-arrestin families in human and Drosophila.	VPS39 USP9X LAMA1 CPD NEDD4 PELO DNAJC10 HECW2 DMD	2.45e-05	313	169	9	38270169
Pubmed	The TIP60 Complex Is a Conserved Coactivator of HIF1A.	MYO9B SAMHD1 DDB1 PELO MTOR IQGAP3	2.78e-05	120	169	6	27320910
Pubmed	Common single-nucleotide polymorphisms in DNA double-strand break repair genes and breast cancer risk.	ATR ATRX RAD50	3.11e-05	13	169	3	19064565
Pubmed	Mutations of the Transcriptional Corepressor ZMYM2 Cause Syndromic Urinary Tract Malformations.	TRPS1 ZNF397 ZBTB26 RAD50 DNAJC10 ZBTB5	3.50e-05	125	169	6	32891193
Pubmed	LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.	MYO1C ATR MYO9B NBAS MTOR CNOT1 IQGAP3	6.26e-05	202	169	7	33005030
Pubmed	Genetic variants of Y chromosome are associated with a protective lipid profile in black men.	USP9Y UTY	7.02e-05	3	169	2	18511697
Pubmed	SOX9 promotes nasopharyngeal carcinoma cell proliferation, migration and invasion through BMP2 and mTOR signaling.	BMP2 MTOR	7.02e-05	3	169	2	31357026
Pubmed	Exposure of cryptic domains in the alpha 1-chain of laminin-1 by elastase stimulates macrophages urokinase and matrix metalloproteinase-9 expression.	LAMA1 PLAU	7.02e-05	3	169	2	11827968
Pubmed	BMP2 downregulates urokinase-type plasminogen activator via p38 MAPK: Implications in C2C12 cells myogenic differentiation.	BMP2 PLAU	7.02e-05	3	169	2	34450502
Pubmed	Enzymatic action of prostate-specific antigen (PSA or hK3): substrate specificity and regulation by Zn(2+), a tight-binding inhibitor.	SEMG1 SEMG2	7.02e-05	3	169	2	11027412
Pubmed	Erythropoietin mediated bone formation is regulated by mTOR signaling.	NFATC1 MTOR	7.02e-05	3	169	2	21898543
Pubmed	Inhibition of Vpx-Mediated SAMHD1 and Vpr-Mediated Host Helicase Transcription Factor Degradation by Selective Disruption of Viral CRL4 (DCAF1) E3 Ubiquitin Ligase Assembly.	SAMHD1 DDB1	7.02e-05	3	169	2	28202763
Pubmed	Diversity of human copy number variation and multicopy genes.	TBC1D3E TBC1D3G	7.02e-05	3	169	2	21030649
Pubmed	Epithelial glycoprotein-330 mediates endocytosis of plasminogen activator-plasminogen activator inhibitor type-1 complexes.	LRP2 PLAU	7.02e-05	3	169	2	8344937
Pubmed	Structural basis of lentiviral subversion of a cellular protein degradation pathway.	SAMHD1 DDB1	7.02e-05	3	169	2	24336198
Pubmed	Bone morphogenetic protein-2, -6, and -7 differently regulate osteogenic differentiation of human periodontal ligament stem cells.	BMP2 BMP6	7.02e-05	3	169	2	23853066
Pubmed	Semenogelin I and semenogelin II, the major gel-forming proteins in human semen, are substrates for transglutaminase.	SEMG1 SEMG2	7.02e-05	3	169	2	9523691
Pubmed	Soluble repulsive guidance molecule c/hemojuvelin is a broad spectrum bone morphogenetic protein (BMP) antagonist and inhibits both BMP2- and BMP6-mediated signaling and gene expression.	BMP2 BMP6	7.02e-05	3	169	2	20530805
Pubmed	Stimulation of calcineurin signaling attenuates the dystrophic pathology in mdx mice.	NFATC1 DMD	7.02e-05	3	169	2	14681302
Pubmed	Localization of the transglutaminase cross-linking site in SVS III, a novel glycoprotein secreted from mouse seminal vesicle.	SEMG1 SEMG2	7.02e-05	3	169	2	11723121
Pubmed	Semenogelins I and II bind zinc and regulate the activity of prostate-specific antigen.	SEMG1 SEMG2	7.02e-05	3	169	2	15563730
Pubmed	Iron, erythropoietin, and inflammation regulate hepcidin in Bmp2-deficient mice, but serum iron fails to induce hepcidin in Bmp6-deficient mice.	BMP2 BMP6	7.02e-05	3	169	2	30478858
Pubmed	Frameshift mutations of immunomodulatory BTN2A1, BTN2A2, and BTNL3 genes in colon cancers.	CHKB BTNL3	7.02e-05	3	169	2	37634314
Pubmed	Sry induces cell proliferation in the mouse gonad.	LAMA1 NR5A1	7.02e-05	3	169	2	10654601
Pubmed	Major role of human KLK14 in seminal clot liquefaction.	SEMG1 SEMG2	7.02e-05	3	169	2	18482984
Pubmed	Postsynaptic recruitment of Dendrin depends on both dendritic mRNA transport and synaptic anchoring.	MAGI1 ACTN1	7.02e-05	3	169	2	16464232
Pubmed	Immunohistochemical detection of neural cell adhesion molecule and laminin in X-linked dystrophic dogs and mdx mice.	LAMA1 DMD	7.02e-05	3	169	2	8040390
Pubmed	Syp-3, a third polymorphic locus for mouse seminal vesicle proteins.	SEMG1 SEMG2	7.02e-05	3	169	2	6626148
Pubmed	Genetic inhibition of PKA phosphorylation of RyR2 prevents dystrophic cardiomyopathy.	RYR2 DMD	7.02e-05	3	169	2	20615971
Pubmed	Enzymatic action of human glandular kallikrein 2 (hK2). Substrate specificity and regulation by Zn2+ and extracellular protease inhibitors.	SEMG1 SEMG2	7.02e-05	3	169	2	10411640
Pubmed	Patterns of expression of murine Vgr-1 and BMP-2a RNA suggest that transforming growth factor-beta-like genes coordinately regulate aspects of embryonic development.	BMP2 BMP6	7.02e-05	3	169	2	2481605
Pubmed	Insulin-like growth factor-1 (IGF-1) enhances the osteogenic activity of bone morphogenetic protein-6 (BMP-6) in vitro and in vivo, and together have a stronger osteogenic effect than when IGF-1 is combined with BMP-2.	BMP2 BMP6	7.02e-05	3	169	2	28256809
Pubmed	Single-nucleotide polymorphisms and haplotypes of bone morphogenetic protein genes and peripheral bone mineral density in young Korean men and women.	BMP2 BMP6	7.02e-05	3	169	2	16604289
Pubmed	Ileal neuroendocrine tumors show elevated activation of mammalian target of rapamycin complex.	ATRX MTOR	7.02e-05	3	169	2	25439321
Pubmed	HIV/simian immunodeficiency virus (SIV) accessory virulence factor Vpx loads the host cell restriction factor SAMHD1 onto the E3 ubiquitin ligase complex CRL4DCAF1.	SAMHD1 DDB1	7.02e-05	3	169	2	22362772
Pubmed	Leaky RyR2 trigger ventricular arrhythmias in Duchenne muscular dystrophy.	RYR2 DMD	7.02e-05	3	169	2	20080623
Pubmed	uPA deficiency exacerbates muscular dystrophy in MDX mice.	PLAU DMD	7.02e-05	3	169	2	17785520
Cytoband	Ensembl 112 genes in cytogenetic band chr17q12	TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F	1.08e-11	149	169	11	chr17q12
Cytoband	17q12	TBC1D3 TBC1D3H TBC1D3C TBC1D3B TBC1D3F	3.45e-05	99	169	5	17q12
Cytoband	Ensembl 112 genes in cytogenetic band chr19q13	ZNF211 ZNF576 EML2 ZNF571 ZNF461 ZNF71 ZNF526 ZNF530 ALDH16A1 ZNF283 ZNF841 ZNF606 ZNF583 NLRP8	1.45e-04	1192	169	14	chr19q13
Cytoband	13q22	MYCBP2 SCEL	7.25e-04	11	169	2	13q22
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZNF211 TRPS1 ZNF576 ZNF571 ZNF397 ZBTB26 ZNF619 ZNF785 ZNF354C ZNF461 ZNF71 ZNF526 ZNF530 ZNF197 ZNF283 ZBTB5 ZNF841 ZNF606 ZNF583 ZNF287	2.10e-08	718	114	20	28
GeneFamily	X-linked mental retardation\|Angiotensin receptors	ATRX USP9X IQSEC2 DMD	3.46e-04	53	114	4	103
GeneFamily	Ubiquitin specific peptidases	USP9X USP9Y USP51 USP27X	4.28e-04	56	114	4	366
GeneFamily	Myosins, class I	MYO1G MYO1C	1.08e-03	8	114	2	1097
GeneFamily	Bone morphogenetic proteins\|Astacins	BMP2 BMP6	2.09e-03	11	114	2	455
CoexpressionAtlas	Mesoderm Day 15_vs_Mesoderm Day 30-Confounder_removed-fold2.0_adjp0.05	TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3G TBC1D3K TBC1D3F	3.80e-08	90	167	9	PCBC_ratio_MESO-15_vs_MESO-30_cfr-2X-p05
CoexpressionAtlas	DE cord blood_vs_DE blastocyst-Confounder_removed-fold2.0_adjp0.05	KCNH8 TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B VENTX NFATC1 TBC1D3G TBC1D3K TBC1D3F	5.05e-07	242	167	12	PCBC_ratio_DE cord blood_vs_DE blastocyst_cfr-2X-p05
CoexpressionAtlas	Endoderm Differentiated Cells-method_mRNA_vs_Endoderm Differentiated Cells-method_NA-Confounder_removed-fold2.0_adjp0.05	TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B VENTX NFATC1 TBC1D3G TBC1D3K TBC1D3F	1.03e-06	213	167	11	PCBC_ratio_DE_from-mRNA_vs_DE_from-ESC_cfr-2X-p05
CoexpressionAtlas	Endoderm Differentiated Cells-reprogram_OSKM-L_vs_Endoderm Differentiated Cells-reprogram_NA-Confounder_removed-fold2.0_adjp0.05	TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B VENTX NFATC1 TBC1D3G TBC1D3K TBC1D3F	1.03e-06	213	167	11	PCBC_ratio_DE_from-OSKM-L_vs_DE_from-ESC_cfr-2X-p05
CoexpressionAtlas	Mesoderm Day 5_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05	TBC1D3 TBC1D3H TBC1D3L TBC1D3D LAMA1 TBC1D3C TBC1D3B BMP2 PLCG2 TBC1D3G TBC1D3K TBC1D3F	9.12e-06	320	167	12	PCBC_ratio_MESO-5_vs_DE_cfr-2X-p05
CoexpressionAtlas	DevelopingKidney_e15.5_Podocyte cells_emap-27915_k-means-cluster#3_top-relative-expression-ranked_1000	ATRX TRPS1 CHN2 THBS2 TBC1D31 PDE5A CHSY3 ARHGAP20	4.01e-05	160	167	8	gudmap_developingKidney_e15.5_Podocyte cells_1000_k3
CoexpressionAtlas	dev gonad_e13.5_F_SupCellPrec_Sry_top-relative-expression-ranked_500	MAGI1 OGT SAMHD1 SESN1 RYR2 TIPARP BMP2 THBS2 RSPH1 NR5A1 ARHGAP20 ZMAT1	1.33e-04	422	167	12	gudmap_dev gonad_e13.5_F_SupCellPrec_Sry_500
CoexpressionAtlas	dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_1000	MAGI1 OGT RPS6KA2 TRPS1 LAMA1 SESN1 ADCY2 ZNF354C RYR2 TIPARP BMP2 THBS2 IGFBP2 SYNE2 NR5A1 ARHGAP20 ZMAT1	1.53e-04	783	167	17	gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_1000
CoexpressionAtlas	FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_500_k-means-cluster#5	ACACB EML6 ADCY2 THBS2 EFCC1 ARHGAP20	1.65e-04	103	167	6	Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_500_K5
ToppCell	renal_medulla_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	MAGI1 WWOX ACACB STK32B EML6 LAMA1 BMP6 RERE UTY	4.71e-08	189	169	9	830d9cd0dd706bce22eb2416f07b2c31c870a05a
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	MAGI1 ARHGAP32 WWOX PTBP2 TRPS1 NBAS RERE DMD UTY	7.33e-08	199	169	9	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	WWOX ACACB STK32B LAMA1 CA10 BMP6 MRPS6 PLAU	3.20e-07	172	169	8	1565f38266891c3acf49778838de134c5dee5460
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	WWOX ACACB STK32B LAMA1 CA10 BMP6 MRPS6 PLAU	5.57e-07	185	169	8	03f64a7132b13a01ba47187e0e15c13ac88f7cb2
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	WWOX ACACB STK32B LAMA1 CA10 BMP6 MRPS6 PLAU	5.80e-07	186	169	8	1850583d23903d08226aeb0edb3e07b0994330e4
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	WWOX ACACB STK32B LAMA1 CA10 BMP6 MRPS6 PLAU	5.80e-07	186	169	8	4dafc215c42e7949f932a3627359c107943b5d6b
ToppCell	frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_VISp_Col6a1_Fezf2\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	DCDC1 NFATC1 PLAU CD200R1L IQGAP3	6.80e-07	44	169	5	2aa44b57544d5264db5b265ae60f7460c5b2a217
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATRX COL6A6 MYCBP2 USP9X RPS6KA2 PDE5A RERE UTY	8.29e-07	195	169	8	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATRX COL6A6 MYCBP2 USP9X RPS6KA2 DDB1 RERE UTY	8.29e-07	195	169	8	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATRX COL6A6 MYCBP2 TIPARP NEDD4 THBS2 PLAU ARHGAP20	8.29e-07	195	169	8	5c86fddd6d0530beecf45ea5ba6b823123847696
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	OGT ATRX EML4 USP9Y ATAD2B SYNE2 TENM1 UTY	9.66e-07	199	169	8	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	Neuronal\|World / cells hierarchy compared to all cells using T-Statistic	MYCBP2 EML6 GABBR2 RYR2 HECW2 CHD5 CHSY3 CSMD1	1.00e-06	200	169	8	48d801219bc771d6c7e151dc88ca4c179988de85
ToppCell	facs-Spleen-nan-18m-Lymphocytic-NK_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STYK1 STK32C SCEL CHN2 SELENON OLFM1 CD200R1L	2.36e-06	157	169	7	a84377028c661f8f3ecae0f6082abdd859faf0c8
ToppCell	PCW_07-8.5-Epithelial-Epithelial_ciliated-epi_ciliated_(14)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	KCNH8 DCDC1 CA10 ADCY2 RSPH1 TTC29 ZNF804B	3.29e-06	165	169	7	0c714e852f912b5749de4cb0895406673979b2e6
ToppCell	PCW_07-8.5-Epithelial-Epithelial_ciliated\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	KCNH8 DCDC1 CA10 ADCY2 RSPH1 TTC29 ZNF804B	3.29e-06	165	169	7	82530f96aaefe28a13bad0474bbad043f127a86c
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ACACB STK32B LAMA1 STK32A BMP6 MRPS6 PLAU	5.42e-06	178	169	7	4df6218b20c2f076c22346d23260964cc0d73e65
ToppCell	Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	TRPS1 ACTN1 PITPNC1 RYR2 THBS2 NFATC1 EFCC1	6.27e-06	182	169	7	ed6ae0fd8653f213fe29906a6a4e0729a62e1b75
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MAGI1 ACACB STK32B LAMA1 CA10 STK32A MRPS6	6.50e-06	183	169	7	31ab55d5f3639f5964541d5eae23044dbda3356e
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MGAM LAMA1 RYR2 TENM1 LRP2 DMD CSMD1	6.73e-06	184	169	7	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MGAM LAMA1 RYR2 TENM1 LRP2 DMD CSMD1	6.73e-06	184	169	7	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MGAM LAMA1 RYR2 TENM1 LRP2 DMD CSMD1	6.73e-06	184	169	7	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	PBMC-Convalescent-Hematopoietic-Platelet-Platelet-plt_4\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CALHM5 BMP6 RSPH1 LGALSL PDE5A DMD ALOX12	6.97e-06	185	169	7	709236097cbfc254796fcc69b5f5178b73dad9bd
ToppCell	PBMC-Convalescent-Hematopoietic-Platelet-Platelet-plt_4\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	CALHM5 BMP6 RSPH1 LGALSL PDE5A DMD ALOX12	6.97e-06	185	169	7	af078a6c4a3e0b54b7d8ab7b30dcd06053ebfd28
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MAGI1 ACACB STK32B LAMA1 CA10 STK32A MRPS6	6.97e-06	185	169	7	898a093757f86be3e18d2ef1f16a71f50ef81dc3
ToppCell	droplet-Kidney-nan-21m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACACB STK32B ZNF354C RYR2 SYNE2 MRPS6 PLAU	7.22e-06	186	169	7	8eafd4bea692f7ef33de27dd53f9d1fe67deaad8
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ST7 ACTN1 RYR2 THBS2 SUSD5 DMD CSMD1	7.22e-06	186	169	7	a95744b8649096bd7cfc3591a02841fa411085b3
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MAGI1 ACACB STK32B LAMA1 CA10 STK32A MRPS6	7.48e-06	187	169	7	b93cf4dfe8ffb89348ee7bccc9f284189f7240a2
ToppCell	remission-Platelet\|World / disease stage, cell group and cell class	CALHM5 LYPLAL1 ACTN1 BMP6 LGALSL PDE5A ALOX12	7.75e-06	188	169	7	fa69f20ef6b8ce620ba342f0984d40ddf259bc3f
ToppCell	PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	KCNH8 ATP8B1 CA10 ADCY2 ZNF804B LRP2 DMD	8.59e-06	191	169	7	60ff989fe99d243a3d52955223680cdd1f1917a4
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-mesenchymal_stem_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A6 MYCBP2 TIPARP NEDD4 THBS2 PLAU ARHGAP20	8.89e-06	192	169	7	11088878043a6ff95ba1970361256a82e434b80a
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	EML6 GABBR2 RYR2 CHD5 OLFM1 CHSY3 CSMD1	1.02e-05	196	169	7	676c56b44ac29f7baecb62f49bb8597cc74c0a88
ToppCell	primary_auditory_cortex_(A1C)-Neuronal\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	EML6 GABBR2 RYR2 CHD5 OLFM1 CHSY3 CSMD1	1.09e-05	198	169	7	6d18b45eda4014759e6dd282d78ffd28df8a6044
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ARHGAP32 EML6 GABBR2 RYR2 CHD5 OLFM1 CSMD1	1.09e-05	198	169	7	8ab40fae14fe02e39bc8c8da187a5cd60c787643
ToppCell	Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MGAM ACTN1 CA10 RYR2 CHD5 TENM1 DMD	1.09e-05	198	169	7	d1827e3707b929e3a3562989a0c11537d344e164
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GABBR2 RYR2 HECW2 CHD5 OLFM1 CHSY3 CSMD1	1.09e-05	198	169	7	0ff30edfd3c133a42e8cb96e1631a1143215f808
ToppCell	Tracheal-NucSeq-Stromal-Chondrocytic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	STK32B ADCY2 TIPARP NEDD4 STK32A BMP6 SUSD5	1.16e-05	200	169	7	b5a54b9baf79aea01f76a161f0a39bbe87eb4945
ToppCell	Neuronal-Inhibitory-iB-iB_4(SST)-STK32A-\|Neuronal / cells hierarchy compared to all cells using T-Statistic	STK32B PITPNC1 ADCY2 STK32A LIPC KCNJ5 TENM1	1.16e-05	200	169	7	6a44439e4a7ce3627271375b04cfcfb9467218f4
ToppCell	Tracheal-NucSeq-Stromal-Chondrocytic-Chondrocyte\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	STK32B ADCY2 TIPARP NEDD4 STK32A BMP6 SUSD5	1.16e-05	200	169	7	f5bd0b30e478dac09f68c46b0781f5f2e7e3c693
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	ATRX MYCBP2 SAMHD1 ATAD2B SYNE2 SIGLEC1 PLCG2	1.16e-05	200	169	7	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	Neuronal-Inhibitory-iB-iB_4(SST)-STK32A\|Neuronal / cells hierarchy compared to all cells using T-Statistic	STK32B PITPNC1 ADCY2 STK32A LIPC KCNJ5 TENM1	1.16e-05	200	169	7	8d51b4f7b7002ee51401ebe5eaca1e8f04bfadd5
ToppCell	LPS_only-Mesenchymal_myocytic-Pericyte\|LPS_only / Treatment groups by lineage, cell group, cell type	ACTN1 RYR2 PELO SUSD5 PDE5A DMD CSMD1	1.16e-05	200	169	7	8c8ef2b19ab5b1bfc0fae6c38a330f464f28e86f
ToppCell	severe-immature_Neutrophil\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	MGAM ACTN1 NEDD4 S100A12 LGALSL PLCG2 POLQ	1.16e-05	200	169	7	5ee43386da8261d2e7602a152e6ba4338d844e08
ToppCell	Neuronal-Inhibitory-iB-iB_4(SST)-STK32A--L4-5\|Neuronal / cells hierarchy compared to all cells using T-Statistic	STK32B PITPNC1 ADCY2 STK32A LIPC KCNJ5 TENM1	1.16e-05	200	169	7	cb1f4b0d66da5b0466ff17b29e7034d451d93e4f
ToppCell	severe-immature_Neutrophil\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	MGAM ACTN1 NEDD4 S100A12 LGALSL PLCG2 POLQ	1.16e-05	200	169	7	a9b87accdaa6956116ab82427e1330e8f007ef94
ToppCell	Globus_pallidus-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Mgp_(Gkn3)-\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	USP9Y SH2D4B MAEL PLCG2 ALOX12	1.52e-05	82	169	5	ea3bdd7b871269eacb81167c6cf59a0e21bf6d83
ToppCell	Globus_pallidus-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Mgp_(Gkn3)--\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	USP9Y SH2D4B MAEL PLCG2 ALOX12	1.52e-05	82	169	5	72d5a55ca7c03e9c54f865524e206b288f242017
ToppCell	Globus_pallidus-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Mgp_(Gkn3)\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	USP9Y SH2D4B MAEL PLCG2 ALOX12	1.52e-05	82	169	5	e500582511814a067852dc3bd78d19937c28ba60
ToppCell	367C-Myeloid-Dendritic-cDC_proliferating_2\|367C / Donor, Lineage, Cell class and subclass (all cells)	MGAM TESK2 MAEL SIGLEC1 POLQ IQGAP3	3.88e-05	164	169	6	0662cd9d21608efacc336e0a582859f3b9a4951d
ToppCell	Tuft-tuft-1\|World / Class top	TRPS1 EML6 PITPNC1 NBAS KCNJ5 PLCG2	4.44e-05	168	169	6	8ddc2ec483ed2c6c0fb2ae521c6861ceb6d32e34
ToppCell	PBMC-Control-Hematopoietic-Platelet-Platelet-plt_4\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CALHM5 RYR2 BMP6 LGALSL PDE5A ALOX12	4.44e-05	168	169	6	2d056cfbb470a088a0682576753535fb4528d48f
ToppCell	PBMC-Control-Hematopoietic-Platelet-Platelet-plt_4\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	CALHM5 RYR2 BMP6 LGALSL PDE5A ALOX12	4.44e-05	168	169	6	2f69e248c6fab1421c0081e01e1920e6ffcde344
ToppCell	3'-Adult-SmallIntestine-Epithelial-epithelial_progenitor_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MGAM ACACB NEDD4 PLCG2 G6PC1 MGAM2	4.44e-05	168	169	6	4e2e4c88ada772e9ba6e72c9ae3a05c063e93318
ToppCell	3'-Adult-SmallIntestine-Epithelial-epithelial_progenitor_cell-TA\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MGAM ACACB NEDD4 PLCG2 G6PC1 MGAM2	4.44e-05	168	169	6	ee4dab089adef2f47a9d39d91934523331a8b81c
ToppCell	CV-Mild-7\|CV / Virus stimulation, Condition and Cluster	ZBTB26 ZNF619 ZNF354C ZNF530 ZBTB5 ZNF606	4.74e-05	170	169	6	25ebde7d2f8ae1afdfaf5876284ff20bb179eb10
ToppCell	facs-Large_Intestine-Proximal-3m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACACB RPS6KA2 CHN2 ADCY2 PLCG2 ALOX12	4.74e-05	170	169	6	17bd7fd25a2657cb536ad47e294332920f759e95
ToppCell	facs-Marrow-T-cells-3m-Myeloid-promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO1G TRPS1 USP9Y LGALS3 VWA5A OLFM1	4.74e-05	170	169	6	a78d9789c3e7c84a36e1bd380192d7aba4a4d443
ToppCell	facs-Marrow-T-cells-3m-Myeloid-monocyte_+_promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO1G TRPS1 USP9Y LGALS3 VWA5A OLFM1	4.74e-05	170	169	6	ff68600b945b3a5437b14e5411b3db800d0ccbe5
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	RYR2 THBS2 LGALSL SUSD5 DMD CSMD1	4.90e-05	171	169	6	4ede831aed364cb5271f49a8b09bb6d0452f9b35
ToppCell	droplet-Liver-LIVER-NPC-1m-Myeloid-myeloid_leukocyte\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO1G TRPS1 SAMHD1 LGALS3 OLFM1 PLCG2	5.06e-05	172	169	6	a125ac2db9c8ece95970a93aa6f7918d1dcef886
ToppCell	droplet-Liver-LIVER-NPC-1m-Myeloid-macrophage/monocyte\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO1G TRPS1 SAMHD1 LGALS3 OLFM1 PLCG2	5.06e-05	172	169	6	6aab59add5b180cee0ca31179c620e89d352d5c1
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	STK32B LAMA1 CA10 BMP6 MRPS6 PLAU	5.57e-05	175	169	6	e5467dacf81f1f913b1719931cf1a7331434a7e7
ToppCell	facs-Large_Intestine-Distal-18m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACACB RPS6KA2 ADCY2 NFATC1 TENM1 PLCG2	5.57e-05	175	169	6	f24b664b9056b5976bf2222e8013f15c09e049ad
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	STK32B LAMA1 PITPNC1 CA10 BMP6 KCNJ5	6.12e-05	178	169	6	dfed0fbf7a73b8a9e00178ec58dc4592b271c344
ToppCell	RV-11._Adipocyte\|RV / Chamber and Cluster_Paper	ACACB MYO1C MYCBP2 RTN4 TRPS1 ARHGAP20	6.12e-05	178	169	6	278bbea5cf8f0589f71675c7a3d00679391b5253
ToppCell	PBMC-Convalescent-Hematopoietic-Platelet-Platelet-plt_3\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	BMP6 IGFBP2 LGALSL PDE5A DMD ALOX12	6.12e-05	178	169	6	850fcd368c4478c57eaedc74544773ea220f41f3
ToppCell	PBMC-Convalescent-Hematopoietic-Platelet\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	CALHM5 BMP6 LGALSL PDE5A DMD ALOX12	6.12e-05	178	169	6	f5d83ad082e31d5601890d245b9fb4f9ef6a062b
ToppCell	PBMC-Convalescent-Hematopoietic-Platelet-Platelet\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	CALHM5 BMP6 LGALSL PDE5A DMD ALOX12	6.12e-05	178	169	6	a2a8fc14f492a4695e6991a357b6626145f1bf7f
ToppCell	PBMC-Convalescent-Hematopoietic-Platelet-Platelet-plt_3\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	BMP6 IGFBP2 LGALSL PDE5A DMD ALOX12	6.12e-05	178	169	6	a16857da9f2907c176213a326112a1b4cbd0e628
ToppCell	PBMC-Convalescent-Hematopoietic-Platelet-Platelet\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CALHM5 BMP6 LGALSL PDE5A DMD ALOX12	6.31e-05	179	169	6	510927794bbd21814eba75286e0801eb1fd2e8a6
ToppCell	PBMC-Convalescent-Hematopoietic-Platelet\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CALHM5 BMP6 LGALSL PDE5A DMD ALOX12	6.31e-05	179	169	6	906a5ebbbac660b6fd498ced09d0ada40a3e64af
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	STK32B LAMA1 PITPNC1 CA10 BMP6 KCNJ5	6.31e-05	179	169	6	d0fa700648db8ce76a8aa689879a25048299fa40
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	STK32B LAMA1 PITPNC1 CA10 BMP6 KCNJ5	6.31e-05	179	169	6	2e49b215b71438400aebb483f2c2c08d5e956961
ToppCell	PBMC-Mild-Hematopoietic-Platelet-Platelet-plt_4\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	CALHM5 LYPLAL1 BMP6 LGALSL PDE5A ALOX12	6.51e-05	180	169	6	1be264962fd4ed0bb59f9b8a6956c4239ca32e05
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	WWOX ACACB STK32B LAMA1 MRPS6 PLAU	6.51e-05	180	169	6	9e09b3dfe344b5d50520711513d389865d73a861
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	STK32B LAMA1 CA10 STK32A MRPS6 PLAU	6.51e-05	180	169	6	eee71184ebed2694d3e60f579a44b3cf7dd2cd35
ToppCell	PBMC-Mild-Hematopoietic-Platelet-Platelet-plt_4\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CALHM5 LYPLAL1 BMP6 LGALSL PDE5A ALOX12	6.51e-05	180	169	6	5568063c2518fadb638e665635061ec10d00fb6a
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	STK32B LAMA1 CA10 STK32A MRPS6 PLAU	6.51e-05	180	169	6	a17dbe03597b81e7a1fe2bf2d23e59e55c615a2a
ToppCell	droplet-Liver-nan-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CALHM5 CPD ZNF354C BMP2 HECW2 ZNF287	6.71e-05	181	169	6	a53f05c4c47465ee62e353716456bd09ab464b23
ToppCell	remission-Platelet\|remission / disease stage, cell group and cell class	CALHM5 BMP6 LGALSL PDE5A DMD ALOX12	6.92e-05	182	169	6	65e2798aacd670cbc3a8c8e9d1a2f7768513bb70
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	STK32C CHN2 CA10 ZNF804B CHSY3 DMD	6.92e-05	182	169	6	205d9ad1ea4b7adee8054496cdde46c9c401a19a
ToppCell	normal-na-Lymphocytic_T-CytoT_GZMK+-male\|normal / PBMC cell types (v2) per disease, treatment status, and sex	ATRX EML4 STYK1 TIPARP SYNE2 UTY	7.13e-05	183	169	6	79defd22b3194dad16db55b9bdd220c09c1e6b90
ToppCell	PBMC-Control-Hematopoietic-Platelet-Platelet-plt_3\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	ACTN1 BMP6 IGFBP2 LGALSL PDE5A ALOX12	7.35e-05	184	169	6	a5d904dd030d9c21be0f8b9ec432025f90fb5b8e
ToppCell	PBMC-Control-Hematopoietic-Platelet-Platelet-plt_3\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ACTN1 BMP6 IGFBP2 LGALSL PDE5A ALOX12	7.35e-05	184	169	6	7617a00b2ebd6c5c9386c39a7e8220fdbf8669ff
ToppCell	LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ARHGAP32 ST7 RPS6KA2 RYR2 PDE5A DMD	7.35e-05	184	169	6	327ff3ac8d2fecdd5d242bdc34f0dfdb1c59a68b
ToppCell	Fetal_29-31_weeks-Mesenchymal-chondrocyte-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	STK32B ADCY2 NEDD4 STK32A SUSD5 ZNF804B	7.57e-05	185	169	6	8ed10ba581849c9c4ac4397226be2b62b4b3b900
ToppCell	Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MYO9B ACTN1 PITPNC1 BMP6 THBS2 NFATC1	7.57e-05	185	169	6	e58a009aaf342be019a909747b1895d5987d4daf
ToppCell	Fetal_29-31_weeks-Mesenchymal-chondrocyte\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	STK32B ADCY2 NEDD4 STK32A SUSD5 ZNF804B	7.57e-05	185	169	6	b8052cebb73f41abe6faf0aa847be7c8ef23ae94
ToppCell	PBMC-Control-Hematopoietic-Platelet-Platelet\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	ACTN1 BMP6 IGFBP2 LGALSL PDE5A ALOX12	7.80e-05	186	169	6	3bf38c80d892a73391009b426dec8ae26a027351
ToppCell	PBMC-Control-Hematopoietic-Platelet\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	ACTN1 BMP6 IGFBP2 LGALSL PDE5A ALOX12	7.80e-05	186	169	6	7496137cebc191aecd1e6ae7fa33118b128fbfe6
ToppCell	PBMC-Control-Hematopoietic-Platelet\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ACTN1 BMP6 IGFBP2 LGALSL PDE5A ALOX12	7.80e-05	186	169	6	9c2fd0bbc968c317a763f52e72fa7182c3c49850
ToppCell	PBMC-Control-Hematopoietic-Platelet-Platelet\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ACTN1 BMP6 IGFBP2 LGALSL PDE5A ALOX12	7.80e-05	186	169	6	06281df5e9665ccc510279bf7e552845c63d5dab
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	STK32B PITPNC1 ADCY2 SYNE2 ZNF804B LRP2	7.80e-05	186	169	6	b1edc341d6684b347dc9e21b34f62f51d095d735
ToppCell	CF\|World / Disease state, Lineage and Cell class	MGAM CPD S100A12 BMP6 SYNE2 PLAU	8.03e-05	187	169	6	eec4d4e4a658e3a61c05745167a1a5e3d39bb43e
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PITPNC1 SH2D4B SPTBN5 BMP6 HECW2 EML1	8.03e-05	187	169	6	35c382c0aabd46906113e5db30ea24bb8e658899
ToppCell	Control-Hematopoietic_Mega-Platelet\|Control / Disease group, lineage and cell class	ACTN1 BMP6 IGFBP2 LGALSL PDE5A ALOX12	8.03e-05	187	169	6	53e9665e1feb02ce8fe78ff4128fd4beacef8471
ToppCell	Control-Hematopoietic_Mega\|Control / Disease group, lineage and cell class	ACTN1 BMP6 IGFBP2 LGALSL PDE5A ALOX12	8.03e-05	187	169	6	7bf98bdc83feb3918dbcf12e87a64fe4d2d41eba
ToppCell	severe_influenza-Platelet\|World / disease group, cell group and cell class (v2)	ACTN1 BMP6 LGALSL PDE5A EFCC1 ALOX12	8.27e-05	188	169	6	b54632baa682aaf51100d44e7f114a54d5edd695
ToppCell	E12.5-Mesenchymal-mesenchymal_fibroblast-tracheal_fibroblast\|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	TAB2 PITPNC1 BMP2 IGFBP2 NFATC1 SUSD5	8.27e-05	188	169	6	9b95730ddd13eb4624321bab3ab4989414977ca3
ToppCell	mild_COVID-19-RBC\|World / disease group, cell group and cell class (v2)	ZBTB26 PLAU POLQ UTY IQGAP3	8.41e-05	117	169	5	85210be67ddc31903764b7fa6d7029d9656753d3
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	RYR2 SUSD5 CHD5 PDE5A DMD CSMD1	8.52e-05	189	169	6	7fbe855bfdb47d35e040b04a80fe4b729a3764e8
Drug	Bemegride [64-65-3]; Down 200; 25.8uM; PC3; HT_HG-U133A	OGT ACACB RPS6KA2 IQSEC2 TAB2 VWA5A B3GNT2 TENM1 CNOT1 ZNF287	1.53e-06	198	161	10	6668_DN
Drug	troglitazone; Up 200; 10uM; HL60; HG-U133A	ARHGAP32 WWOX MYO1C VPS39 ZNF576 DNAJC10 VWA5A TESK2 B3GNT2 UTY	1.53e-06	198	161	10	370_UP
Drug	NSC236997	MGAM ERCC5 OGT CHKB DDB1 ADCY2 RYR2 TIPARP LIPC IGFBP2 MTOR PDE5A G6PC1 ALOX12 PRM2	7.02e-06	539	161	15	CID000005300
Drug	Dapsone [80-08-0]; Up 200; 16.2uM; PC3; HT_HG-U133A	WWOX ACACB EML4 RPS6KA2 EML2 CPD SCEL CHN2 ATAD2B	1.03e-05	194	161	9	1827_UP
Disease	aortic valve stenosis (is_marker_for)	OGT LGALS3 NFATC1	2.32e-05	11	156	3	DOID:1712 (is_marker_for)
Disease	Mental Retardation, X-Linked 1	USP9X IQSEC2 DMD USP27X	2.41e-05	32	156	4	C2931498
Disease	Duchenne muscular dystrophy (implicated_via_orthology)	EML4 EML2 EML1 DMD	3.88e-05	36	156	4	DOID:11723 (implicated_via_orthology)
Disease	amino acid measurement	WWOX DCDC1 ACACB RPS6KA2 STYK1 STK32C CA10 RYR2 NBAS SUSD5 LRP2 CSMD1 MGAM2	6.85e-05	678	156	13	EFO_0005134
Disease	Colorectal Carcinoma	RTN4 LAMA1 EML2 STK32C BMP2 BMP6 NFATC1 TOMM40L CHD5 TENM1 LRP2 DMD NLRP8	9.70e-05	702	156	13	C0009402
Disease	anorectal malformation	THBS2 SUSD5 NLRP8	1.32e-04	19	156	3	MONDO_0019938
Disease	epithelial cell adhesion molecule measurement	ERCC5 RTN4 EML6 B3GNT2	1.55e-04	51	156	4	EFO_0010574
Disease	Metastatic melanoma	RPS6KA2 STK32B STK32A MTOR	1.94e-04	54	156	4	C0278883
Disease	breast cancer (implicated_via_orthology)	ATR RAD50 PLAU	3.06e-04	25	156	3	DOID:1612 (implicated_via_orthology)
Disease	Accommodative esotropia	MYCBP2 SCEL	4.11e-04	6	156	2	HP_0020046
Disease	Muscular Dystrophy	SELENON DMD	7.62e-04	8	156	2	C0026850
Disease	Urologic Neoplasms	WWOX ATR	7.62e-04	8	156	2	C0042076
Disease	Cancer of Urinary Tract	WWOX ATR	7.62e-04	8	156	2	C0751571
Disease	Anti-measles virus IgG measurement	MYCBP2 SCEL	7.62e-04	8	156	2	EFO_0009355
Disease	Schizophrenia	MAGI1 ARHGAP32 MYO9B VPS39 RTN4 LAMA1 UGT1A3 ZNF530 MTOR B3GNT2 LRP2 CSMD1 ALOX12	8.65e-04	883	156	13	C0036341
Disease	Nephritis	LGALS3 PLAU	9.76e-04	9	156	2	C0027697
Disease	glioblastoma (implicated_via_orthology)	USP51 USP27X	9.76e-04	9	156	2	DOID:3068 (implicated_via_orthology)
Disease	immunoglobulin M measurement	TESK2 SIGLEC1	9.76e-04	9	156	2	EFO_0020466
Disease	Stomach Neoplasms	WWOX ATR DDB1 LGALS3 BMP2 NBAS PLAU	1.06e-03	297	156	7	C0038356
Disease	mean platelet volume	ARHGAP32 MYO1C COL6A6 MYO9B EML6 ACTN1 NFATC1 TESK2 ATAD2B SYNE2 PLCG2 ALOX12 RNF138 ARAP1	1.08e-03	1020	156	14	EFO_0004584
Disease	Malignant neoplasm of stomach	WWOX ATR DDB1 LGALS3 BMP2 NBAS PLAU	1.12e-03	300	156	7	C0024623
Disease	Marfan syndrome (implicated_via_orthology)	BMP2 BMP6	1.22e-03	10	156	2	DOID:14323 (implicated_via_orthology)
Disease	response to carboplatin, response to antineoplastic agent	PLCG2 CSMD1	1.22e-03	10	156	2	GO_0097327, GO_0097328
Disease	triacylglycerol 54:1 measurement	SAMHD1 MAU2	1.22e-03	10	156	2	EFO_0010419
Disease	testosterone measurement	MAGI1 WWOX DCDC1 MYO9B EML4 IQSEC2 TRPS1 MAU2 ZNF785 BMP6 VENTX NFATC1 B3GNT2 SYNE2 VARS1 ARAP1	1.22e-03	1275	156	16	EFO_0004908
Disease	prostate cancer (is_marker_for)	AMD1 BMP2 BMP6 PLAU ALOX12	1.47e-03	156	156	5	DOID:10283 (is_marker_for)
Disease	46,XY partial gonadal dysgenesis	WWOX NR5A1	1.48e-03	11	156	2	C4510744
Disease	level of Ceramide (d40:1) in blood serum	SYNE2 G6PC1	1.48e-03	11	156	2	OBA_2045185
Disease	Hereditary hemochromatosis	BMP2 BMP6	1.77e-03	12	156	2	C0392514
Disease	Hemochromatosis	BMP2 BMP6	1.77e-03	12	156	2	C0018995
Disease	serum IgG glycosylation measurement	MAGI1 TRPS1 RYR2 USF3 ZNF804B OLFM1 PLCG2 CSMD1 CCDC40	1.93e-03	523	156	9	EFO_0005193
Disease	middle temporal gyrus volume measurement, Alzheimer's disease biomarker measurement	MYCBP2 SCEL	2.08e-03	13	156	2	EFO_0006514, EFO_0010316
Disease	Alzheimer disease, dementia, family history of Alzheimer’s disease	KCNH8 TRPS1 EML6	2.11e-03	48	156	3	EFO_0009268, MONDO_0001627, MONDO_0004975
Disease	FEV/FEC ratio	MGAM LYPLAL1 EML4 TRPS1 ADCY2 ZNF354C SPTBN5 NFATC1 LGALSL SYNE2 MRPS6 PLAU CSMD1 ARHGAP20 ARAP1	2.25e-03	1228	156	15	EFO_0004713
Disease	platelet component distribution width	MYO1G ZNF211 MYO9B ACTN1 CHKB SH2D4B TESK2 ATAD2B SIGLEC1 PLCG2 CCDC40	2.33e-03	755	156	11	EFO_0007984
Disease	cortical thickness	MAGI1 WWOX DCDC1 MYCBP2 PTBP2 RPS6KA2 TRPS1 LAMA1 EML2 BMP2 BMP6 MAEL RERE EML1	2.42e-03	1113	156	14	EFO_0004840
Disease	triacylglycerol 52:1 measurement	NFATC1 CSMD1	2.42e-03	14	156	2	EFO_0010413
Disease	lysophosphatidylcholine 15:0 measurement	LIPC TTC29	2.42e-03	14	156	2	EFO_0020941
Disease	alcohol consumption measurement	MAGI1 MGAM ACACB RTN4 TRPS1 SAMHD1 ACTN1 SELENON SPTBN5 NBAS MTOR OLFM1 NR5A1 RERE CSMD1	2.51e-03	1242	156	15	EFO_0007878
Disease	Proteinuria	STK32B LRP2	2.79e-03	15	156	2	HP_0000093
Disease	phospholipids in medium HDL measurement	TRPS1 LIPC TOMM40L	3.11e-03	55	156	3	EFO_0022295
Disease	amygdala volume change measurement	ZNF804B CSMD1	3.17e-03	16	156	2	EFO_0021490
Disease	body mass index, type 2 diabetes mellitus	MTOR ARAP1	3.17e-03	16	156	2	EFO_0004340, MONDO_0005148
Disease	ankle brachial index	NBAS DMD	3.17e-03	16	156	2	EFO_0003912
Disease	complex trait	TRPS1 MAU2 ZNF785 NBAS BMP6 LIPC	3.28e-03	271	156	6	EFO_0010578
Disease	ocular sarcoidosis	MAGI1 STK32C LIPC LRP2	3.40e-03	116	156	4	EFO_0010723
Disease	response to citalopram, antidepressant-induced dizziness, response to buspirone, response to antidepressant	LGALS3 DMD	3.59e-03	17	156	2	EFO_0006321, EFO_0006329, EFO_0006330, GO_0036276
Disease	level of Sphingomyelin (d32:1) in blood serum	LIPC SYNE2	3.59e-03	17	156	2	OBA_2045173
Disease	immature platelet measurement	MYO1G MYO9B ACTN1 TESK2	3.73e-03	119	156	4	EFO_0803541
Disease	Insulin Resistance	ACACB LIPC IGFBP2	3.98e-03	60	156	3	C0021655
Disease	Insulin Sensitivity	ACACB LIPC IGFBP2	3.98e-03	60	156	3	C0920563
Disease	C-C motif chemokine 3 measurement	TBC1D3B PLCG2	4.02e-03	18	156	2	EFO_0008051
Disease	glucose measurement	MYCBP2 RTN4 EML6 SESN1 OLFM1 MRPS6 ARAP1	4.21e-03	380	156	7	EFO_0004468
Disease	fasting blood glucose measurement	RTN4 TRPS1 NFATC1 CSMD1 VARS1 ARAP1	4.33e-03	287	156	6	EFO_0004465
Disease	colorectal health	WWOX EML4 ST7 RYR2 CSMD1	4.39e-03	201	156	5	EFO_0008460
Disease	Alzheimer disease	MYO1C STK32B SH2D4B BMP2 LIPC PLCG2 CSMD1 ARHGAP20	4.40e-03	485	156	8	MONDO_0004975
Disease	inosine measurement	RPS6KA2 DMD	4.48e-03	19	156	2	EFO_0010503
Disease	age at onset, smoking initiation	MYCBP2 SCEL	4.48e-03	19	156	2	EFO_0004847, EFO_0005670
Disease	Malignant neoplasm of breast	WWOX VPS39 ATP8B1 NEDD4 BMP2 IGBP1 MTOR CHD5 SYNE2 TENM1 DMD G6PC1 NLRP8	4.73e-03	1074	156	13	C0006142
Disease	Hereditary Diffuse Gastric Cancer	WWOX DDB1 LGALS3 BMP2 NBAS PLAU	4.78e-03	293	156	6	C1708349
Disease	renal cell carcinoma (is_marker_for)	BMP6 MTOR PLAU ALOX12	4.83e-03	128	156	4	DOID:4450 (is_marker_for)
Disease	daytime rest measurement	KCNH8 WWOX MYCBP2 STK32A ZBTB5 RERE	4.94e-03	295	156	6	EFO_0007828
Disease	CCL4 measurement	TBC1D3 TBC1D3F	4.96e-03	20	156	2	EFO_0004751
Disease	triacylglycerol 46:1 measurement	NFATC1 CSMD1	4.96e-03	20	156	2	EFO_0010401
Disease	sphingomyelin 22:0 measurement	OLFM1 CSMD1	4.96e-03	20	156	2	EFO_0010395
Disease	end stage renal disease (implicated_via_orthology)	LIPC MTOR	4.96e-03	20	156	2	DOID:783 (implicated_via_orthology)
Disease	Astigmatism	MYO1G MAGI1 EML6 MAEL	4.96e-03	129	156	4	HP_0000483
Disease	myocardial infarction (implicated_via_orthology)	RAD50 MTOR PDE5A	5.20e-03	66	156	3	DOID:5844 (implicated_via_orthology)

Protein segments in the cluster

Peptide	Gene	Start	Entry
QDEFDRHVLGHTQLY	UGT1A3	86	P35503
LAEHQRFHTGEQLYT	ZNF354C	371	Q86Y25
AEELRRGYQEAQHLH	CEP295NL	111	Q96MC4
FRNQFHAVVHLYRDG	BTNL3	56	Q6UXE8
RQAQEHYNATQKGHV	ENKD1	231	Q9H0I2
HGTLEDQLSHLRQYE	ACTN1	661	P12814
LIHFYSDHSQNRQGF	CSMD1	2061	Q96PZ7
HHYEQQQEDLARNLG	CHD5	1326	Q8TDI0
DGDVQLAQQLLHYHA	ALDH16A1	136	Q8IZ83
LQGEIEAHTDVYHNL	DMD	2741	P11532
QEQQLHFIRHYLAEA	CHKB	306	Q9Y259
LGNNSSFHHRINIYE	BMP2	161	P12643
RHEVGYVLGQLQHEA	DOHH	206	Q9BU89
LATGLDQYLQEVFHH	EFCC1	51	Q9HA90
INGQIYGDHRDASQH	ATP8B1	471	O43520
QNGAHEVFNHREVNY	CRYZ	191	Q08257
DEQLNDLYHNHQRTV	RAD50	301	Q92878
DLVFELVNQLQYHTH	TIPARP	221	Q7Z3E1
AFLDAVRLYRQHQGH	NIBAN3	241	Q86XR2
NVHHGNVQETYRYLS	KCNJ5	61	P48544
QHARHLEVQILADQY	ACACB	496	O00763
THHFERYQHNRDLVG	HECW2	961	Q9P2P5
KHCHQQFEYRDGQII	DCDC1	1161	M0R2J8
GHQLFDFYHRIQTLS	LGALSL	141	Q3ZCW2
FERGHNQATVLQNLY	MAEL	186	Q96JY0
DHELQQTIRDNLYRH	MAGI1	126	Q96QZ7
HEIGTHYFRGINNLQ	KIAA0895	331	Q8NCT3
RTHTDGRIFYINHNI	NEDD4	901	P46934
ANVYGLGEHVHQQYR	MGAM2	216	Q2M2H8
TGNQHLRYLEIQHVE	NLRP8	756	Q86W28
LRRNSYGIQNHHEVS	ATAD2B	241	Q9ULI0
TNVYGLGEHVHQQYR	MGAM	261	O43451
ESQYQNLRETQFHHR	IQSEC2	86	Q5JU85
VAVNDAHLLQYNHRV	LGALS3	211	P17931
HHIYVLNQVDHFRFN	B4GALT7	126	Q9UBV7
DGNFHRGYHLQVLVT	CD200R1L	131	Q6Q8B3
GLYFHINQTLREAHF	FAM104A	161	Q969W3
HLQRAREHFINYLTQ	IGBP1	101	P78318
CHLFYNEQQEARGVH	IGFBP2	306	P18065
DHRGVNNSYIQRSEH	PDE5A	656	O76074
NGHQILYNVTLFHVI	OLFM1	466	Q99784
FLHHQNRYGSEQEFV	ENDOU	246	P21128
LGLYHNNNQFFHDVE	NFATC1	126	O95644
FLELYRHIAQHGFNA	LIPC	256	P11150
DYNGHHRRQVIASDL	LRP2	1626	P98164
VYLHDFQRFLIHEQQ	PLCG2	241	P16885
DFQLHEIQYHLLNTH	ALOX12	351	P18054
QVHDQHYVTRLGHRF	NUDT7	156	P0C024
HNKLEQHQVYGARSE	ARHGAP32	1511	A7KAX9
QTEILYQRVNFQIHH	NBAS	1361	A2RRP1
YQRVNFQIHHEGGEN	NBAS	1366	A2RRP1
LRYQATGLHFRHTDN	IQGAP3	91	Q86VI3
DHYLTQAEIQGNINH	IQGAP3	276	Q86VI3
HRSDEQQHYFNTPFQ	PPTC7	171	Q8NI37
QTLNYRLFHDGKHFV	CHN2	101	P52757
HAHVLGDYSQVLFER	ADCY2	781	Q08462
QQVNHFQKDSIYRHP	ATRX	176	P46100
HNELLLRIGEHYQQV	ATR	1076	Q13535
NVLHDFGIQSTHYLQ	G6PC1	6	P35575
QHYSTLHRVVDNGLQ	CALHM5	276	Q8N5C1
IIAREFYNLHHQAEG	POLQ	356	O75417
ELGVNLYEVQQHLVH	CCDC40	326	Q4G0X9
SHQGYPHRNFQEEIE	AMD1	121	P17707
IYQVLQEHQHRDSDL	BMP6	276	P22004
VHNIIAIADGYQQQH	CPD	1256	O75976
LQQVTGHDHYNADLK	C17orf98	106	A8MV24
IHLAYRNHQDVAGVF	LYPLAL1	131	Q5VWZ2
QYFLNHGVKVDARDH	ANKS3	186	Q6ZW76
RHQRIQDFNYTDHTL	GABBR2	381	O75899
LYNVEEQLQRHYAGH	EML1	256	O00423
EQLQRHYAGHNDDVK	EML1	261	O00423
YSVEEQRQRHYLGHN	EML2	91	O95834
NYEERTQRHYLGHTD	EML4	296	Q9HC35
QQHSQRLYLGHDDDI	EML6	716	Q6ZMW3
TVVFNQSNIHEYEGH	DNAJC10	526	Q8IXB1
AFSGEVQLIHYNHEL	CA10	151	Q9NS85
GHIFYVLGNHRESNN	MAU2	506	Q9Y6X3
ETHTLQEHNLANYLF	RYR2	4906	Q92736
VLHAHQFLQNEYALS	DDB1	801	Q16531
NTHIGAALREVEHYF	COL6A6	1076	A6NMZ7
ERGQLQEAIEHYRHA	OGT	101	O15294
TRFYDQLNHHIFELV	MTOR	61	P42345
RYLFGVLHNIEQHSS	ARHGAP20	486	Q9P2F6
ERHQAQIDHYLGLAN	RTN4	1156	Q9NQC3
HDQNDYEVGQRHGLE	VARS1	596	P26640
REVSEHGRHLQQYFN	USP9X	2166	Q93008
NAEIQFHIAHLYETQ	UTY	201	O14607
LVFDHIYRQVQHGKE	NR5A1	306	Q13285
NVGQRQARHYHQQIE	SUSD5	611	O60279
QQTYHAHRSDALQLG	PLAU	101	P00749
ISAHSQQHNRGGYFL	MRPS6	51	P82932
SYLVNLHVNDFLHVG	SESN1	131	Q9Y6P5
DHQGNIYVFDLHGNR	TBC1D31	61	Q96DN5
QALIDLHNYNLGENH	PTBP2	506	Q9UKA9
IQGFHLIDADRIYQH	SYNE2	1246	Q8WXH0
VQNLDGHVREHDSYQ	SYNE2	2241	Q8WXH0
DLQSQNIYHHGREGS	TAB2	81	Q9NYJ8
HHLGIQNNFDYKRFI	SAMHD1	321	Q9Y3Z3
EHLEGIVNIFHQYSV	S100A12	6	P80511
AHQNQADYAVLQLHG	LAMA1	2756	P25391
QQHSGHIRRQYEDEG	ERCC5	256	P28715
NKGHYQNVVEVREEH	SEMG1	216	P04279
NFVSHLNQRHQFDYG	RNF138	206	Q8WVD3
DQELYQFTVNGTHLH	TENM1	1541	Q9UKZ4
NAHYLENLHFTIEGR	TENM1	2556	Q9UKZ4
NKGHYQNVVDVREEH	SEMG2	216	Q02383
QTLARHHHENFVGYQ	MYCBP2	3396	O75592
YEQVVQAIQRHIHFD	PELO	186	Q9BRX2
SVYQHLVQDRHNEND	RERE	196	Q9P2R6
QEGTAELIHLNHRYQ	RSPH1	146	Q8WYR4
GDLRYHLQQNVHFKE	STK32A	106	Q8WU08
YRRSQQLQHHGSQYE	ST7	271	Q9NRC1
SYNNNVDHLGIVHET	TBC1D3L	41	B9A6J9
YGQSLSAVRHLQEQH	SPTBN5	2921	Q9NRC6
GDLRYHLQQNVQFSE	STK32C	176	Q86UX6
DDVFVNTHHILNYLN	B3GNT2	246	Q9NY97
RALHLEQYTGLFEQH	ARAP1	16	Q96P48
LFHENYEHNRKGYIQ	CHSY3	366	Q70JA7
HHLQEYIEYGQQSRD	CNOT1	986	A5YKK6
HEVQDFLGRIQFHQY	STYK1	156	Q6J9G0
SYNNNVDHLGIVHET	TBC1D3B	41	A6NDS4
SYNNNVDHLGIVHET	TBC1D3H	41	P0C7X1
ERSHEVYRQQLHGQE	PRM2	11	P04554
YDFTTHIQRGLHRNN	TRPS1	1256	Q9UHF7
HLAGYRQQDAHEFLI	USP51	441	Q70EK9
HLAGYRQQDAHEFLI	USP27X	156	A6NNY8
HFEQIFQQLNYQRLH	ZBTB5	6	O15062
TYNRNLIEHQRIHSG	ZNF197	856	O14709
HINHVEGNINSYYDR	ZNF804B	1106	A4D1E1
AYRQGANLTQHQRIH	ZNF287	656	Q9HBT7
YHGDSHLQLERINVY	TUBB8	36	Q3ZCM7
SYNNNVDHLGIVHET	TBC1D3F	41	A6NER0
ENYGRVVLNRHNSHD	SCEL	56	O95171
NGTVVHHINANYFLD	SELENON	531	Q9NZV5
HHGNGQFTEKRVYLN	PITPNC1	51	Q9UKF7
NFSLIYHQRVHTGER	ZNF211	381	Q13398
VNHLGHFYLVQLLQD	WWOX	231	Q9NZC7
FGENHLVQLIYHQNA	VWA5A	676	O00534
QQQAGQLRERHHLYQ	USF3	1476	Q68DE3
SYNNNVDHLGIVHET	TBC1D3E	41	A0A087X179
TYFGVRALHRLHQFQ	SIGLEC1	1626	Q9BZZ2
RREVSEHGHHLQQYF	USP9Y	2166	O00507
ERSNLVYHQRNHTGE	ZNF841	716	Q6ZN19
FHDRRLQYTEHQQLE	UBP1	121	Q9NZI7
AAEHYEAFHQLTQGR	TTC29	201	Q8NA56
LVQHQRIHSGDEAYI	ZNF397	496	Q8NF99
GAHASYYHRANEQVQ	TOMM40L	216	Q969M1
HQDAHLRESANQIQY	ZNF526	126	Q8TF50
RELGQSHEQEARLYH	SH2D4B	256	Q5SQS7
GDLRYHLQQNVHFTE	STK32B	106	Q9NY57
SYNNNVDHLGIVHET	TBC1D3D	41	A0A087WVF3
NIYLIHHQRFHTGER	ZNF530	391	Q6P9A1
DFAQEAGLHQHYIRH	ZNF576	151	Q9H609
HFRGLLQNVHLVFEN	THBS2	201	P35442
VHQGQLHALTEYINS	TESK2	121	Q96S53
SYNNNVDHLGIVHET	TBC1D3G	41	Q6DHY5
SYNNNVDHLGIVHET	TBC1D3	41	Q8IZP1
FLQHQRFHTGEQLYK	ZNF619	371	Q8N2I2
QSAYLIEHQRIHTGE	ZNF71	421	Q9NQZ8
FIYGSQLSEHQRIHR	ZNF571	511	Q7Z3V5
SYNNNVDHLGIVHET	TBC1D3K	41	A0A087X1G2
QYAHLAQHQRVHTGE	ZNF583	391	Q96ND8
AFSQIAYLDQHQRVH	ZNF583	416	Q96ND8
EQVRTLEGVFQHHQY	VENTX	101	O95231
ENRVSEIEQNHLHNY	ZBTB26	226	Q9HCK0
SYNNNVDHLGIVHET	TBC1D3I	41	A0A087WXS9
SYNNNVDHLGIVHET	TBC1D3C	41	Q6IPX1
QRRYLLQHQFIHTGE	ZNF785	211	A8K8V0
AFNYGSELTLHQRIH	ZNF461	281	Q8TAF7
SFNEHPRLHVGENQY	ZNF606	331	Q8WXB4
HERTVQYLQHLGTEN	VPS39	536	Q96JC1
QYLQHLGTENLHLIF	VPS39	541	Q96JC1
QFESQRISHYEGEKH	ZMAT1	66	Q5H9K5
SAYQLNVHQRFHTGE	ZNF283	246	Q8N7M2
SHYQVVQEGHLQFLR	KCNH8	996	Q96L42
VQQLHGNNIHFTDGY	RPS6KA2	401	Q15349
NHGERNFHIFYQLLE	MYO1C	231	O00159
VLKQHVGERNFHAFY	MYO1G	191	B0I1T2
AVQEHNGHVFASYQV	MYO9B	1626	Q13459